-
Roche Full Year 2025 Financial Report
Financial statements
Roche's 2025 financial results show a 7% sales growth, driven by innovative drugs and diagnostics. Core operating profit rose 13%, with strong performance across key markets. The company remains optimistic for 2026, focusing on sustainable growth.
-
-
Roche 2025 H1 Financial Report
Roche
Roche reports 7% growth in H1 2025, with Phesgo up 55% and Polivy up 46%. China revenue rises 9%. Strong gains in hematology, immunology, and ophthalmology offset legacy drug declines.
-
Chugai Taps Gero's AI in $1B+ Aging R&D Deal
Roche
Chugai Pharmaceutical teams up with AI biotech Gero in a $1B+ deal to develop antibody therapies targeting aging-related diseases. The partnership leverages Gero’s AI platform and supports Chugai’s global innovation strategy.
-
-
Pharma's $158B U.S. Manufacturing Surge
Market Trend
Major pharmaceutical companies pledge $158 billion to U.S. manufacturing to sidestep tariff threats, funding facilities from California to North Carolina. Lilly, J&J, Novartis, Roche and Regeneron drive billions in reshoring investments, creating thousands of jobs.
-
-
-
-
Roche's Q1 2025 Financial report
Financial statements
Roche Q1 2025 financial results show 6% revenue growth, driven by strong demand for innovative drugs and diagnostics. China leads international growth, while the company makes strategic investments in the US and global R&D.
汤原县|
乌兰察布市|
敦煌市|
新化县|
大丰市|
苍溪县|
仁寿县|
曲沃县|
怀集县|
贺兰县|
合肥市|
淳化县|
扎鲁特旗|
广东省|
巍山|
洪江市|
库尔勒市|
亳州市|
珠海市|
和政县|
南昌市|
堆龙德庆县|
闸北区|
远安县|
封开县|
独山县|
买车|
沽源县|
辽源市|
玉环县|
红安县|
合江县|
镇巴县|
兰州市|
临洮县|
乐都县|
商南县|
澄城县|
会泽县|
涟源市|
平舆县|